Theriva Biologics

(NYSEMKT) SYN

Current PriceN/A

Market CapN/A

Since IPO (2006)-100%

5 Year-100%

1 Year-73%

1 Month+65%

Theriva Biologics Financials at a Glance

Market Cap

N/A

Revenue (TTM)

$0.00

Net Income (TTM)

$22.97M

EPS (TTM)

N/A

P/E Ratio

N/A

Dividend

N/A

Beta (Volatility)

N/A

Dividend

N/A

Beta (Volatility)

N/A

Price

N/A

Volume

N/A

Open

N/A

Price

N/A

Volume

N/A

Open

N/A

Previous Close

N/A

Daily Range

N/A

52-Week Range

N/A

Dividend

N/A

Beta (Volatility)

N/A

Price

N/A

Volume

N/A

Open

N/A

Previous Close

N/A

Daily Range

N/A

52-Week Range

N/A

SYN News

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Theriva Biologics

Industry

Biotechnology

Sector

Health Care

Employees

CEO

Steven A. Shallcross, MBA, CPA

Website

www.therivabio.com

Headquarters

Rockville, MD 20850, US

SYN Financials

Key Financial Metrics (TTM)

Gross Margin

Operating Margin

Net Income Margin

Return on Equity

-2%

Return on Capital

-45%

Return on Assets

-60%

Earnings Yield

N/A

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

N/A

Shares Outstanding

N/A

Volume

N/A

Avg. Volume

N/A

Financials (TTM)

Gross Profit

$0.00

Operating Income

$24.05M

EBITDA

$24.05M

Operating Cash Flow

$16.67M

Capital Expenditure

$35.00K

Free Cash Flow

$16.70M

Cash & ST Invst.

$13.06M

Total Debt

$958.00K

Theriva Biologics Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q1 2026YOY CHG

Revenue

$0.00

N/A

Gross Profit

$0.00

N/A

Gross Margin

0.00%

N/A

Market Cap

N/A

Market Cap/Employee

N/A

Employees

N/A

Net Income

$2.04M

+52.7%

EBITDA

$2.13M

+51.8%

Quarterly Fundamentals

Name

Q1 2026YOY CHG

Net Cash

$12.36M

+42.7%

Accounts Receivable

$0.00

N/A

Inventory

$0.00

N/A

Long Term Debt

$1.52M

+107.9%

Short Term Debt

$545.00K

-12.0%

Return on Assets

-60.05%

N/A

Return on Invested Capital

-45.49%

N/A

Free Cash Flow

$2.46M

+48.4%

Operating Cash Flow

$2.46M

+48.4%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

WENAAnew Medical, Inc.

WENAAnew Medical, Inc.$0.73-3.84%

IMNNImunon, Inc.

IMNNImunon, Inc.$2.77-1.07%

PIRSPieris Pharmaceuticals, Inc.

PIRSPieris Pharmaceuticals, Inc.$13.60-15.58%

CYADCelyad Oncology S.A.

CYADCelyad Oncology S.A.$0.47-12.96%

NYMXFNymox Pharmaceutical Corporation

NYMXFNymox Pharmaceutical Corporation$0.07+8.65%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

DGXXDigi Power X

DGXXDigi Power X$5.11+0.29%

NOKNokia

NOKNokia$13.42+0.02%

CCLCarnival Corp.

CCLCarnival Corp.$25.77+0.00%

NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF

NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF$5.81+0.02%

RIGTransocean

RIGTransocean$6.25-0.09%

MUMicron Technology

MUMicron Technology$640.20+0.11%

CIFRCipher Mining

CIFRCipher Mining$22.10+0.24%

Questions About SYN

What is the current price of Theriva Biologics?

Theriva Biologics is trading at N/A per share.

What is the 52-week range for Theriva Biologics?

Over the past 52 weeks, Theriva Biologics has traded between N/A and N/A.

How much debt does Theriva Biologics have?

As of the most recent reporting period, Theriva Biologics reported total debt of $2.63M.

How much cash does Theriva Biologics have on hand?

Theriva Biologics reported $13.06M in cash and cash equivalents in its most recent financial results.

What is Theriva Biologics’s dividend yield?

Theriva Biologics does not currently have a dividend yield.

Theriva Biologics

Theriva Biologics Financials at a Glance

SYN News

1 Biotech Soars While Another Crashes

Is Coach a Rule Breaker?

eBay Made Easy

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Theriva Biologics

SYN Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Theriva Biologics Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About SYN

What is the current price of Theriva Biologics?

What is the 52-week range for Theriva Biologics?

How much debt does Theriva Biologics have?

How much cash does Theriva Biologics have on hand?

What is Theriva Biologics’s dividend yield?

Premium Investing Services